Biogen Idec yesterday reported $286m (€207m) in third-quarter sales of its high-profile new multiple sclerosis drug Tecfidera, providing fresh evidence that the medicine is off to an impressive launch and exceeding expectations.
Tue, 29 Oct, 2013
SHARES in Elan — the Dublin-headquartered pharmaceutical firm — fell by nearly 5% yesterday after it announced a significant amendment to trials of its leading test treatment for Alzheimer’s disease and analysts reduced their faith in the drug making it to market.
Fri, 03 Apr, 2009
Elan have announced that Dr Lars Ekman, currently president of Research and Development, member of the Operating Committee and the Board of Directors, will transition from his current operational role to become an advisor as a member of the Board of Directors.
Thu, 09 Aug, 2007